A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
Clinical trial NCT06257966 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06257966
- Sponsor
- Beijing Dongfang Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-17
- Primary completion
- 2026-10-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.